Sarepta Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
/ 
Frequently asked questions
To buy Sarepta Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sarepta Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sarepta Therapeutics Inc. is SRPT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sarepta Therapeutics Inc. has its primary listing on NASDAQ. You can trade Sarepta Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sarepta Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Sarepta Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Sarepta Therapeutics Inc. or others.